Medtronic gets FDA approval for Brainsense device
Medtronic (NYSE:MDT), which has operations worldwide, is reportedly looking at adjusting its manufacturing footprint amid ...
Medical device maker Medtronic is looking at options to modify its global manufacturing footprint as part of efforts to ...
The biggest technical challenge for adaptive deep brain stimulation (aDBS) is how small brain signals are, Medtronic's Scott ...
First Selectman Michael Freda said he's working with Medtronics to improve the area around its North Haven site though the ...
A series of important developments in the healthcare sector includes Medtronic adapting to tariff threats, Hims & Hers facing ...
Medtronic's agnostic approach to global challenges, including tariffs and AI, ensures success and innovation in healthcare ...
Shares of Medtronic ( MDT -6.63%) were sinking 7.3% as of 11:21 a.m. ET on Tuesday. The decline came after the medical device ...
T here is still no cure for Parkinson’s disease, but the U.S. Food and Drug Administration (FDA) approved a new deep brain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results